Tag Archives: Cann Group

Australia to Permit Medicinal Cannabis Exports in Bid to Capture Lucrative Market

Australia to Permit Medicinal Cannabis Exports in Bid to Capture Market

Australia to Permit Medicinal Cannabis Exports in Bid to Capture Market

Australia said on Thursday it planned to become the fourth country in the world to legalise medicinal marijuana exports in a bid to score a piece of the estimated $55 billion global market.

Aurora Cannabis operational update

Operational Update: Aurora Cannabis Surpasses 19,000 Patients; Record Monthly Revenue, Shipments, Grams Sold

VANCOUVER, Aug. 31, 2017 /Weed Wire/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to provide the following operational update.

Australia Cautiously Enters Medical Marijuana Market

Australia Cautiously Enters Medical Marijuana Market

At a secret location in Australia’s southeast, Peter Crock delicately tends to a two-month-old cannabis cutting. Barely knee high, it is one of about 50 government-sanctioned “mother plants” to be cloned for future generations of crops for the country’s fledgling medicinal marijuana industry.

Aurora Cannabis operational update

Aurora Cannabis to be Cornerstone Investor in Australian Medical Cannabis IPO

VANCOUVER, March 28, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that it has committed to taking part in the initial public offering (“IPO”) of Cann Group Limited (“Cann Group”) on the Australian Stock Exchange (“ASX”) as the cornerstone investor.

Australia-Coat-of-Arms

The Office of Drug Control Grants First Commercial Medicinal Cannabis Licence

CANBERRA, Australia, March 8, 2017 /Weed Wire/ — Today the Office of Drug control issued the second licence under the medicinal cannabis provisions of the Narcotic Drugs Act 1967. This is the first commercial medicinal cannabis licence and authorises the cultivation and production of Australian grown cannabis into the manufacture chain and for subsequent therapeutic supply to Australian patients.


Top